申请人:Lavielle Gilbert
公开号:US20050059675A1
公开(公告)日:2005-03-17
A compound of formula (I):
wherein:
R
1
and R
2
together form a benzo ring optionally substituted by halogen or by alkyl, alkoxy, cyano, nitro, hydroxy, amino, alkylamino, dialkylamino or trifluoromethyl, and R
3
and R
4
represent hydrogen, or
R
1
and R
4
represent hydrogen and R
2
and R
3
together form a benzo ring optionally substituted by halogen or by alkyl, alkoxy, cyano, nitro, hydroxy, amino, alkylamino, dialkylamino or trifluoromethyl, or
R
1
and R
2
represent hydrogen and R
3
and R
4
together form a benzo ring optionally substituted by halogen or by alkyl, alkoxy, cyano, nitro, hydroxy, amino, alkylamino, dialkylamino or trifluoromethyl, addition salts thereof with a pharmaceutically acceptable acid or base, and
methods of treating conditions susceptible to α
2
-AR/5-HT
2C
antagonists.
式(I)的化合物:其中:R1和R2一起形成一个苯环,可以选择地由卤素或烷基、烷氧基、氰基、硝基、羟基、氨基、烷基氨基、二烷基氨基或三氟甲基取代,而R3和R4代表氢,或者R1和R4代表氢,R2和R3一起形成一个苯环,可以选择地由卤素或烷基、烷氧基、氰基、硝基、羟基、氨基、烷基氨基、二烷基氨基或三氟甲基取代,或者R1和R2代表氢,R3和R4一起形成一个苯环,可以选择地由卤素或烷基、烷氧基、氰基、硝基、羟基、氨基、烷基氨基、二烷基氨基或三氟甲基取代,以及它们与药用酸或碱形成的加合物,以及治疗对α2-AR/5-HT2C拮抗剂敏感的疾病的方法。